FDA Wants To Team Up With USPTO Over Drug Pricing
Citing the goals of increased competition and less expensive drugs, the U.S. Food and Drug Administration says it wants to work alongside the U.S. Patent and Trademark Office to help rein...To view the full article, register now.
Already a subscriber? Click here to view full article